Alvotech
ALVO
17 hedge funds and large institutions have $158M invested in Alvotech in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
7.81% more ownership
Funds ownership: 0% → 7.81% (+7.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCL
Bracebridge Capital LLC
Boston,
Massachusetts
|
+$65M |
| 2 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
+$59M |
| 3 |
LC
Lodbrok Capital
London,
United Kingdom
|
+$19.3M |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$9.31M |
| 5 |
Temasek Holdings
Singapore
|
+$9.31M |
Top Sellers
ALVO Hedge Fund Activity: Q2 2022 in Review
17 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Alvotech (ALVO) for Q2 2022, worth a combined $158M.
Buyers outnumbered sellers: 17 funds opened new ALVO positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bracebridge Capital LLC, opening a new position worth an estimated $65M.
- 17 institutional investors held Alvotech (ALVO) as of Q2 2022, up from 0 in Q1 2022.
- Funds reported $158M of Alvotech stock for Q2 2022.
- 17 funds opened new Alvotech positions in Q2 2022 and 0 closed out, a net change of +17 holders.
- The largest Alvotech buyer in Q2 2022 was Bracebridge Capital LLC, an estimated $65M added.
Based on aggregated 13F filings for Q2 2022.